Ausgabe 2/2022
Inhalt (8 Artikel)
Exebacase: A Novel Approach to the Treatment of Staphylococcal Infections
Matthew W. McCarthy
Pharmacokinetics and Safety of Ferric Pyrophosphate Citrate in Chinese Subjects with and without Hemodialysis-Dependent Stage 5 Chronic Kidney Disease
Liangying Gan, Panpan Xie, Yan Tan, Gang Wei, Xiaojuan Yuan, Zhifei Lu, Raymond Pratt, Yongchun Zhou, Ai-Min Hui, Kexin Li, Yi Fang, Li Zuo
First-in-Human Phase I Study of the Novel Injectable Calcimimetic Agent Upacicalcet in Healthy Adult Japanese Participants
Fumihiko Koiwa, Rie Yazawa, Masafumi Fukagawa, Daisuke Honda, Tadao Akizawa
A Phase I, Open-label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of AMG 986 in Healthy Japanese Subjects
Ashit Trivedi, Omar Mather, Silvia Vega, Shauna Hutton, Jennifer Hellawell, Edward Lee
Evaluation of the Pharmacokinetics and Safety of AMG 986 Tablet and Capsule Formulations in Healthy Adult Subjects: A Phase I, Open-Label, Randomized Study
Ashit Trivedi, Y.-H. Kiang, Robert E. Saw, Guilong Charles Cheng, Omar Mather, Silvia Vega, Jennifer Hellawell, Edward Lee
Hydroxychloroquine Blood Concentrations Can Be Clinically Relevant Also After Drug Discontinuation
Simona De Gregori, Francesco Falaschi, Alessia Ballesio, Alessandra Fusco, Elisa Cremonte, Roberta Canta, Umberto Sabatini, Mariadelfina Molinaro, Carlo Soffiantini, Alba Nardone, Alessandro Vicentini, Annalisa De Silvestri, Antonio Di Sabatino
Preclinical and Toxicology Studies of BRD5529, a Selective Inhibitor of CARD9
Theodore J. Kottom, Kyle Schaefbauer, Eva M. Carmona, Eunhee S. Yi, Andrew H. Limper
Evaluation of the Effect of Food on the Pharmacokinetics of SHR6390, An Oral CDK4/6 Inhibitor, in Healthy Volunteers
Yan-ping Liu, Ming-hui Hu, Ping-ping Lin, Ting Li, Shu-qin Liu, Yu-ya Wang, Shao-rong Li, Xiang-kun Li, Chen-jing Wang, Yu Cao